Overview


According to FutureWise analysis, the market for Drug Discount Card is expected to grow with a CAGR of 7.25% over the forecast period 2024-2032, and reach a market value of US$ 27.13 billion by 2031.

A drug discount card, also called a prescription discount card or pharmacy savings card, is a card that offers discounts on the price of prescription medications. These cards are typically provided by various organizations, including pharmaceutical companies, non-profit organizations, government agencies, and private companies. Drug discount cards can be obtained from various sources, including pharmacies, healthcare providers, websites, or by mail. They are usually free and do not require any special qualifications to obtain. While going to a pharmacy to pick up a prescription, present the drug discount card and the prescription. The pharmacist will then apply any available discounts associated with the card. The discount card can provide savings in different ways. It may offer a percentage off the retail price of the medication or a fixed dollar amount off the cost. In some cases, it may not be able to use a drug discount card with government healthcare programs like Medicare or Medicaid.

Drug discount cards are of two types, branded or generic, and can be valuable for individuals seeking to save money on their prescription medications. Branded drug discount cards are typically associated with specific pharmaceutical companies. These cards are designed to provide discounts on brand-name medications produced by the company offering the card. Branded cards are tailored to a particular pharmaceutical company's products, so they are most effective for individuals who regularly use medications produced by that specific company. Branded cards only apply to medications produced by the company offering the card. They may not provide discounts for drugs from other manufacturers. At the same time, generic drug discount cards focus on providing discounts for generic medications. These cards are not associated with any particular pharmaceutical company and are intended to help individuals save on generic versions of prescription drugs. Generic cards can be used for various generic medications produced by various manufacturers.

FutureWise Market Research has published a report that provides an insightful analysis drug discount card market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts drug discount card market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver  
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Recent Developments in Drug Discount Card Market:

  • In 2022, GoodRx launched a new Gold subscription plan, providing access to lower prescription prices, free delivery, and 24/7 doctor visits for a monthly fee. This expanded GoodRx's monetization strategies beyond discounted drugs. Also, they introduced a discounted drug card, offering users reduced prices on a wide range of prescription medications, even without a subscription.

The increasing prevalence of accessibility and cost-saving benefits of drug discount cards serve as substantial drivers in the market. These cards provide consumers with an immediate and tangible value proposition, making them an attractive option for individuals seeking affordable prescription medications. Their easy availability and straightforward application process ensure that a broad demographic may access these benefits, transcending socio-economic barriers. Furthermore, the potential for pharmacies and healthcare providers to form strategic partnerships with drug discount card companies increases customer retention and facilitates a collaborative approach toward improving healthcare affordability, ultimately benefiting both patients and medical professionals. This mutually beneficial deal encourages the widespread adoption and utilization of drug discount cards, further propelling growth in the market. Also, integrating supplementary services with drug discounts presents a major opportunity for providers to differentiate themselves in the market. By offering value-added features like telehealth consultations and personalized medication management, providers may address a broader spectrum of healthcare needs, enhancing the overall patient experience. Telehealth consultations provide convenient access to healthcare professionals, especially those with limited mobility or remote areas. Personalized medication management ensures patients receive tailored guidance on dosage, potential interactions, and lifestyle adjustments, leading to improved medication adherence and health outcomes. However, the market faces major restraints from innovative newcomers and established players. Armed with novel approaches, new entrants might disrupt the status quo and capture market share. Likewise, established entities expanding their services may exert competitive pressure, leveraging existing resources and customer bases. Additionally, the availability of lower-cost generic medications poses a significant challenge to drug discount cards. As generics become more prevalent, their affordability may outshine the benefits offered by discount cards, potentially diminishing their perceived value proposition. This shift in consumer preferences towards generics could reduce the demand for drug discount cards, necessitating adaptation, and innovation within the market to remain competitive, thus hindering the market growth over the forecast period.

By Type

  • Branded Cards
  • Generic Cards

By Distribution Channel

  • Online
  • Retail Stores
  • Mail Order
  • Clinics
  • Hospitals
  • Others

By Eligibility

  • Uninsured
  • Insured
  • Senior Citizens
  • Others

By Application

  • Essential Medicines
  • Chronic Diseases
  • Oncology
  • Rare Diseases
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is primarily driven by factors such as the higher prices of branded drugs, which made the discounts more appealing, the increasing adoption of discount cards by the uninsured population, and the increasing adoption of online platforms and m-health apps in the U.S., which is propelling market growth. In addition, strategic collaborations between discount card platforms and pharma companies provide growth opportunities and are driving market expansion. In June 2022, a pharmaceutical company partnered with a drug savings platform. The deal gave app users exclusive access to savings on two antidiabetic brands. Such partnerships provide discounts specifically on costly branded drugs, benefitting consumers. The collaborations are mutually beneficial for pharma companies and discount platforms. Also, in March 2022, Capsule and SingleCare partnered to integrate Capsule's delivery services into SingleCare's platform, improving access to discounted prescriptions.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Drug Discount Card Market By Type, By Distribution Channel, By Eligibility, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Drug Discount Card Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Drug Discount Card Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Drug Discount Card Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Drug Discount Card Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Branded Cards
        2. Generic Cards

  • 8.  Drug Discount Card Market, By Distribution Channel Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Online
        2. Retail Stores
        3. Mail Order
        4. Clinics
        5. Hospitals
        6. Others

  • 9.  Drug Discount Card Market, By Eligibility Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Uninsured
        2. Insured
        3. Senior Citizens
        4. Others

  • 10.  Drug Discount Card Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Essential Medicines
        2. Chronic Diseases
        3. Oncology
        4. Rare Diseases
        5. Others

  • 11.  North America Drug Discount Card Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Drug Discount Card Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Drug Discount Card Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Drug Discount Card Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032  

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GoodRx
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. SingleCare
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. WellCard Savings
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. RxSaver
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Optum Perks
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Kroger Prescription Savings Club
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. ScriptSave
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Walmart Rx Savings Program
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Prescription Hope
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. FamilyWize
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

Partner

Our Clients